ADAMO, Marianna
 Distribuzione geografica
Continente #
NA - Nord America 3.046
EU - Europa 1.349
AS - Asia 811
OC - Oceania 7
SA - Sud America 6
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 5.229
Nazione #
US - Stati Uniti d'America 3.032
HK - Hong Kong 429
DE - Germania 293
CN - Cina 280
FI - Finlandia 209
IT - Italia 193
GB - Regno Unito 174
IE - Irlanda 164
UA - Ucraina 135
BE - Belgio 58
IN - India 32
RU - Federazione Russa 32
SE - Svezia 29
FR - Francia 25
JP - Giappone 15
CA - Canada 13
SG - Singapore 13
TR - Turchia 13
AU - Australia 7
KR - Corea 7
NL - Olanda 7
ES - Italia 6
IR - Iran 5
AT - Austria 4
EU - Europa 4
ID - Indonesia 4
TW - Taiwan 4
AR - Argentina 3
EG - Egitto 3
GR - Grecia 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
BR - Brasile 2
CH - Svizzera 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
VN - Vietnam 1
Totale 5.229
Città #
Chandler 449
Hong Kong 427
Fairfield 364
Ashburn 263
Princeton 238
Helsinki 183
Houston 169
Woodbridge 165
Dublin 164
Seattle 154
Beijing 145
Wilmington 139
New York 138
Cambridge 130
Jacksonville 116
Ann Arbor 73
Brussels 58
Shanghai 46
London 35
Frankfurt am Main 31
San Diego 29
Brescia 28
Des Moines 27
Milan 27
Pune 24
Lappeenranta 23
Brindisi 19
Nanjing 15
Prevalle 15
Kilburn 14
Washington 14
Chiswick 13
Rome 10
San Francisco 9
Strasbourg 9
Acton 8
Changsha 8
Tokyo 8
Chicago 7
Jiaxing 7
Shenyang 7
Nanchang 6
New Bedfont 6
North York 6
Prescot 6
Trieste 6
Dearborn 5
Falkenstein 5
Haikou 5
Hanover 5
Hebei 5
Hounslow 5
Jinan 5
Kocaeli 5
Zhengzhou 5
Amsterdam 4
Augusta 4
Curno 4
Gangnam-gu 4
Melbourne 4
Nürnberg 4
Taipei 4
Toronto 4
Venice 4
Vienna 4
A Coruña 3
Berlin 3
Bologna 3
Canberra 3
Edinburgh 3
Kunming 3
Lancaster 3
Madrid 3
Marburg 3
Miami 3
Norwalk 3
Quezon City 3
Ravenna 3
Riyadh 3
Singapore 3
Soncino 3
Taiyuan 3
Tianjin 3
Warsaw 3
Bari 2
Belluno 2
Bergamo 2
Bernareggio 2
Calcinato 2
Caravaggio 2
Castrezzato 2
Chennai 2
Clorinda 2
Codigoro 2
Conegliano 2
Eindhoven 2
Fujinomiya 2
Gavardo 2
Hamburg 2
Jakarta 2
Totale 4.012
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 209
Effectiveness of MitraClip therapy in patients with refractory heart failure 145
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 144
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 139
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 136
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 135
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 101
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 99
January 2020 at a glance: translational medicine, predictors of outcome and treatments 78
September 2019 at a glance: focus on devices 74
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 74
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 68
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 66
Highlights in heart failure 64
December 2019 at a glance: economic burden, co-morbidities, and prognosis 61
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 59
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 58
Highlights in valvular heart diseases 57
April 2020 at a glance: epidemiology, prevention, and biomarkers 56
October 2019 at a glance: epidemiology, prevention, and modes of death 53
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 52
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 51
Percutaneous treatment of mitral regurgitation: looking for a final model 51
Role of nutrition in heart failure patients 50
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatment 50
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 50
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 50
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 49
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 49
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 49
Transcatheter therapies for tricuspid valve regurgitation 48
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 47
Il dronedarone: in quali pazienti e con quali associazioni? 43
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 43
February 2020 at a glance: acute heart failure and cardio-oncology 41
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 41
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 40
Renal failure after trans-catheter aortic valve implantation 38
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 37
July 2020 at a glance: focus on imaging and cardiomyopathies 36
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 35
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients 34
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 33
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 33
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 33
Patient with heart failure: importance to treat valvular diseases 33
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry 32
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 32
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 31
March 2020 at a glance: heart failure with preserved ejection fraction, left atrial myopathy, atrial fibrillation and cardiac amyloidosis 31
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 31
Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study 30
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 28
Heart failure in the last year: progress and perspective 28
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitation 28
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 28
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 27
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 27
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 27
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 26
Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE) | [Bioequivalenza ed eccipienti: il caso del tirofiban. Un “warning” della Società Italiana di Cardiologia Interventistica (SICI-GISE)] 26
[Advances in heart failure treatment: a summary of 50 years of evolution] 25
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 25
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 25
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 24
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 24
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 24
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration 24
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial 24
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 23
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 23
Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: Feasibility and safety 23
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 22
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 22
March 2023 at a glance: pathophysiology, medical therapy and devices 21
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 21
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 21
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 21
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 20
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 20
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 20
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 20
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 20
OCT Appraisal of Residual Thrombus Burden in Patients With STEMI Undergoing Intraprocedural Versus Post-Stenting Prolonged Bivalirudin Infusion: The MATRIX OCT Study 20
Comparison of three contemporary surgical scores for predicting all-cause mortality of patients undergoing percutaneous mitral valve repair with the MitraClip system (from the multicenter GRASP-IT registry) 20
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 19
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 19
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 19
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion 19
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 19
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 19
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 19
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) 18
August 2022 at a glance: focus on heart failure with preserved ejection fraction and cardiac amyloidosis 18
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 18
Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair 18
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 18
Transcatheter mitral valve replacement or repair for secondary mitral regurgitation: a propensity score-matched analysis 17
Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature 17
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 17
Totale 4.230
Categoria #
all - tutte 55.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201974 0 0 0 0 0 0 0 0 5 14 32 23
2019/2020456 45 15 18 33 26 48 42 50 31 76 38 34
2020/20211.091 77 145 44 141 41 75 162 102 71 118 71 44
2021/2022728 23 102 22 83 21 57 15 76 34 51 42 202
2022/20231.376 150 48 20 115 101 377 12 144 210 22 91 86
2023/20241.561 114 40 187 157 122 243 144 62 492 0 0 0
Totale 5.433